IPS IPSOS

Disclosure of trading in own shares under a share buyback programme (4 to 8 March 2024)

Disclosure of trading in own shares under a share buyback programme (4 to 8 March 2024)

12 March 2024

Disclosure of trading in own shares

under a share buyback programme

Period : From 4 to 8 March 2024

Issuer’s registered name: Ipsos

Issuer’s Identification code: 9695002OY2X35E9X8W87

Financial instrument reference: Ordinary shares – ISIN code FR0000073298

Reporting of transactions in aggregated form (per day and per trading venue)

Issuer name Issuer Code Transaction date ISIN Code Daily total volume (in number of shares) Daily weighted average price of shares acquired Platform
      ISIN Code (ISO 6166)     MIC code (ISO 10383)
IPSOS 9695002OY2X35E9X8W87 4-Mar-24 FR0000073298 8 091 64,7901 XPAR
IPSOS 9695002OY2X35E9X8W87 4-Mar-24 FR0000073298 3 909 64,7572 DXE
IPSOS 9695002OY2X35E9X8W87 4-Mar-24 FR0000073298 1 000 64,7573 TQE
IPSOS 9695002OY2X35E9X8W87 4-Mar-24 FR0000073298 1 000 64,7517 AQE
IPSOS 9695002OY2X35E9X8W87 5-Mar-24 FR0000073298 8 697 64,6253 XPAR
IPSOS 9695002OY2X35E9X8W87 5-Mar-24 FR0000073298 3 508 64,5976 DXE
IPSOS 9695002OY2X35E9X8W87 5-Mar-24 FR0000073298 894 64,6223 TQE
IPSOS 9695002OY2X35E9X8W87 5-Mar-24 FR0000073298 901 64,5994 AQE
IPSOS 9695002OY2X35E9X8W87 6-Mar-24 FR0000073298 7 400 65,0248 XPAR
IPSOS 9695002OY2X35E9X8W87 6-Mar-24 FR0000073298 5 000 64,8264 DXE
IPSOS 9695002OY2X35E9X8W87 6-Mar-24 FR0000073298 1 100 64,9355 TQE
IPSOS 9695002OY2X35E9X8W87 6-Mar-24 FR0000073298 1 500 64,7896 AQE
IPSOS 9695002OY2X35E9X8W87 7-Mar-24 FR0000073298 7 000 65,0023 XPAR
IPSOS 9695002OY2X35E9X8W87 7-Mar-24 FR0000073298 4 771 64,9657 DXE
IPSOS 9695002OY2X35E9X8W87 7-Mar-24 FR0000073298 1 200 64,9789 TQE
IPSOS 9695002OY2X35E9X8W87 7-Mar-24 FR0000073298 1 000 64,9921 AQE
IPSOS 9695002OY2X35E9X8W87 8-Mar-24 FR0000073298 7 000 65,0429 XPAR
IPSOS 9695002OY2X35E9X8W87 8-Mar-24 FR0000073298 4 800 65,0182 DXE
IPSOS 9695002OY2X35E9X8W87 8-Mar-24 FR0000073298 1 200 65,0194 TQE
IPSOS 9695002OY2X35E9X8W87 8-Mar-24 FR0000073298 1 000 65,0515 AQE

Detailed presentation by transaction:

A detailed presentation by transaction is available on the Company's website (), in the section on regulated information, in the chapter entitled: “Share buyback programs and share buyback declarations”: .

 

Attachment



EN
12/03/2024

Underlying

IPSIPSOS

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on IPSOS

 PRESS RELEASE
Free
IPS IPSOS

[Press Release] 2025 results in line with guidance - Launch of Horizon...

[Press Release] 2025 results in line with guidance - Launch of Horizons strategic plan 2025 results in line with guidanceLaunch of Horizons strategic plan Paris, February 24th, 2026 - , one of the world's leading market research and opinion polling companies, today announces its full-year 2025 results. Revenue, organic growth and operating margin rate, communicated on a preliminary basis at the Investor Day on 22 January, are confirmed. Revenue: €2,525 million Total growth: +3.4%Organic growth: +0.6% Operating margin: €309 million Operating margin rate: 12.3%Operating margin rate at const...

46m 1 EN
 PRESS RELEASE
Free
IPS IPSOS

[Communiqué de presse] Résultats 2025 en ligne avec les prévisions - L...

[Communiqué de presse] Résultats 2025 en ligne avec les prévisions - Lancement du plan stratégique Horizons Résultats 2025 en ligne avec les prévisionsLancement du plan stratégique Horizons Paris, 24 février 2026 – , l’une des principales sociétés mondiales d’études de marché et d’enquêtes d’opinion, publie aujourd’hui ses résultats annuels 2025. Le chiffre d’affaires, la croissance organique et le taux de marge opérationnelle, communiqués à titre préliminaire lors de la Journée Investisseurs du 22 janvier dernier, sont confirmés. Chiffre d'affaires : 2 525 millions d'euros croissance to...

46m 1 EN
 PRESS RELEASE
Free
IPS IPSOS

[Press Release] Appointment of Nathan Brumby as Chief Platforms and Te...

[Press Release] Appointment of Nathan Brumby as Chief Platforms and Technology Officer Appointment of Nathan Brumbyas Chief Platforms and Technology Officer Paris, 23 February 2026 - , one of the world's leading market research and opinion polling companies, is pleased to announce the appointment of Nathan Brumby as Chief Platforms and Technology Officer, effective 16 February 2026. Based in Paris, he will report directly to Jean Laurent Poitou, Chief Executive Officer of Ipsos. This appointment is part of the Group’s ongoing organizational evolution aimed at strengthening its technology ...

February 23, 2026 1 EN
 PRESS RELEASE
Free
IPS IPSOS

[Communiqué de presse] Nomination de Nathan Brumby au poste de Chief P...

[Communiqué de presse] Nomination de Nathan Brumby au poste de Chief Platforms and Technology Officer Nomination de Nathan Brumby au poste de Chief Platforms and Technology Officer Paris, 23 février 2026 – , l’une des principales sociétés mondiales d’études de marché et d’enquêtes d’opinion, annonce la nomination de Nathan Brumby en qualité de Chief Platforms and Technology Officer, à compter du 16 février 2026. Basé à Paris, il reportera directement à Jean Laurent Poitou, Directeur Général d’Ipsos. Cette nomination s’inscrit dans la poursuite de l’évolution organisationnelle du Groupe, v...

February 23, 2026 1 EN
 PRESS RELEASE
Free
IPS IPSOS

Ipsos: Disclosure of trading in own shares under a share buyback progr...

Ipsos: Disclosure of trading in own shares under a share buyback programme (9 to 13 February 2026) 17th February 2026 Disclosure of trading in own shares under a share buyback programme Period : From 9 to 13 February 2026 Issuer’s registered name: Ipsos Issuer’s Identification code: 9695002OY2X35E9X8W87 Financial instrument reference: Ordinary shares – ISIN code FR0000073298 Reporting of transactions in aggregated form (per day and per trading venue) Issuer nameIssuer CodeTransaction dateISIN CodeDaily total volume (in number of shares)Daily weighted average price of shares acquiredP...

February 17, 2026 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch